Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study.

Journal:

Journal of Clinical Oncology

Published:

2025-07-22

DOI:

10.1200/jco-25-00387

Affiliations:

7

Authors:

17

Go to article

Institutions	Authors	Share
Princess Alexandra Hospital, Australia	5.500000	0.32
The University of Queensland (UQ), Australia	5.500000	0.32
Royal Brisbane and Women's Hospital (RBWH), Australia	2.500000	0.15
Chris O'Brien Lifehouse, Australia	1.500000	0.09
The University of Sydney (USYD), Australia	1.000000	0.06
Peter MacCallum Cancer Centre (Peter Mac), Australia	0.500000	0.03
Royal Prince Alfred Hospital (RPAH), USYD, Australia	0.500000	0.03

Interested in Clinical Sciences?